Diabetes screening among underserved adults with severe mental illness who take antipsychotic medications

JAMA Internal Medicine

Volumn 175, Issue 12, 2015, Pages 1977-1979

  Mangurian, Christina ^a   Newcomer, John W ^b   Vittinghoff, Eric ^c   Creasman, Jennifer M ^c   Knapp, Penelope ^d   Fuentes Afflick, Elena ^c   Schillinger, Dean ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; NEUROLEPTIC AGENT;

ADULT; BIPOLAR DISORDER; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SCREENING; UNITED STATES; ADOLESCENT; AGED; CALIFORNIA; COMPLICATION; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW UP; MALE; MASS SCREENING; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; PROCEDURES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; CALIFORNIA; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84964862114     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.6098     Document Type: Letter

References (6)

1. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.
2. Institute of Medicine. Committee on Crossing the Quality Chasm: Improving the Quality of Health Care for Mental and Substance-Use Conditions. Washington, DC: National Academies Press; 2006.
3. Osborn DP, Wright CA, Levy G, King MB, Deo R, Nazareth I. Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis. BMC Psychiatry. 2008;8:84.
4. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(suppl 1):1-93.
5. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596-601.
6. Parks J, Radke AQ, Mazade NA. Measurement of Health Status for People With Serious Mental Illness. Alexandria, VA: National Association of State Mental Health Program Directors; 2008.